Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

Journal of Clinical Investigation

Volumn 114, Issue 3, 2004, Pages 438-446

  Phillips, Roderick J ^a   Burdick, Marie D ^a   Hong, Kurt ^a   Lutz, Marin A ^a   Murray, Lynne A ^a   Xue, Ying Ying ^a   Belperio, John A ^a   Keane, Michael P ^a   Strieter, Robert M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CD45 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CXCR4; COLLAGEN; NEUTRALIZING ANTIBODY; RNA; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROCYTE; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; ANTIGENS, CD45; BLEOMYCIN; CHEMOKINES, CXC; CHEMOTAXIS; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; FIBROBLASTS; HUMANS; KINETICS; LUNG; MICE; MICE, SCID; MUSCLE, SMOOTH; PULMONARY FIBROSIS; RECEPTORS, COMPLEMENT 3B; RECEPTORS, CXCR4;

EID: 4043055316     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420997     Document Type: Article

References (50)

1. Coultas, D.B., Zumwalt, R.E., Black, W.C., and Sobonya, R.E. 1994. The epidemiology of interstitial lung diseases. Am. J. Respir. Crit. Care Med. 150:967-972.
2. Perez, A., Rogers, R.M., and Dauber, J.H. 2003. The prognosis of idiopathic pulmonary Fibrosis. Am. J. Respir. Cell Mol. Biol. 29(3 Suppl.):S19-S26.
3. du Bois, R. 1997. Diffuse lung disease: a view for the future. Sarcoidosis Vasc. Diffuse Lung Dis. 14:23-30.
4. Dacic, S., and Yousem, S.A. 2003. Histologic classification of idiopathic chronic interstitial pneumonias. Am. J. Respir. Cell Mol. Biol. 29(3 Suppl.):S5-S9.
5. Bucala, R., Spiegel, L.A., Chesney J., Hogan, M., and Cerami, A. 1994. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1:71-81.
6. Abe, R., Donnelly, S.C., Peng, T., Bucala, R., and Metz, C.N. 2001. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol. 166:7556-7562.
7. Metz, C.N. 2003. Fibrocytes: a unique cell population implicated in wound healing. Cell. Mol. Life Sci. 60:1342-1350.
8. Chesney, J., Metz, C., Stavitsky, A.B., Bacher, M., and Bucala, R. 1998. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160:419-425.
9. Phan, S.H. 2003. Fibroblast phenotypes in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 29(3 Suppl.):S87-S92.
10. Fries, K.M., et al. 1994. Evidence of fibroblast heterogeneity and the role of fibroblast subpopulations in fibrosis. Clin. Immunol. Immunopathol. 72:283-292.
11. Schmidt, M., Sun, G., Stacey, M.A., Mori, L., and Mattoli, S. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171:380-389.
12. Chandler, D.B. 1990. Possible mechanisms of bleomycin-induced fibrosis. Clin. Chest Med. 11:21-30.
13. Blease, K., et al. 2002. State-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am. J. Pathol. 160:481-490.
14. Epperly, M.W., Guo, H., Gretton, J.E., and Greenberger, J.S. 2003. Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J. Respir. Cell Mol. Biol. 29:213-224.
15. Muller, A., et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50-56.
16. Phillips, R.J., et al. 2003. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am. J. Respir. Crit. Care Med. 167:1676-1686.
17. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature. 392:565-568.
18. Homey, B., Muller, A., and Zlotnik, A. 2002. Chemokines: agents for the immunotherapy of cancer? Nat. Rev. Immunol. 2:175-184.
19. Ashcroft, T., Simpson, J.M., and Timbrell, V. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41:467-470.
20. Murphy, P.M., et al. 2000. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52:145-176.
21. Murphy, P.M. 2002. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54:227-229.
22. Premack, B.A., and Schall, T.J. 1996. Chemokine receptors: gateways to inflammation and infection. Nat. Med. 2:1174-1178.
23. Hashimoto, N., Jin, H., Liu, T., Chensue, S.W., and Phan, S.H. 2004. Bone marrow-derived progenitor cells in pulmonary fibrosis. J. Clin. Invest. 113:243-252. doi:10.1172/JCI200418847.
24. Derdak, S., et al. 1992. Differential collagen and fibronectin production by Thy 1+ and Thy 1-lung fibroblast subpopulations. Am. J. Physiol. 263:L283-L290.
25. McIntosh, J.C., Hagood, J.S., Richardson, T.L., and Simecka, J.W. 1994. Thy1 (+) and (-) lung fibrosis subpopulations in LEW and F344 rats. Eur. Respir. J. 7:2131-2138.
26. Silvera, M.R., Sempowski, G.D., and Phipps, R.P. 1994. Expression of TGF-beta isoforms by Thy-1+ and Thy-1- pulmonary fibroblast subsets: evidence for TGF-beta as a regulator of IL-1-dependent stimulation of IL-6. Lymphokine Cytokine Res. 13:277-285.
27. Wilborn, J., et al. 1995. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95:1861-1868.
28. Nozaki, Y., Liu, T., Hatano, K., Gharaee-Kermani, M., and Phan, S-H. 2000. Induction of telomerase activity in fibroblasts from bleomycin-injured lungs. Am. J. Respir. Cell Mol. Biol. 23:460-465.
29. Liu, T., Nozaki, Y., and Phan, S.H. 2002. Regulation of telomerase activity in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 26:534-540.
30. Hashimoto, S., Gon, Y., Takeshita, I., Maruoka, S., and Horie, T. 2001. IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway. J. Allergy Clin. Immunol. 107:1001-1008.
31. Niki, T., et al. 1999. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology. 29:520-527.
32. Sundberg, C., Ivarsson, M., Gerdin, B., and Rubin, K. 1996. Pericytes as collagen-producing cells in excessive dermal scarring. Lab. Invest. 74:452-466.
33. Sato, M., Suzuki, S., and Senoo, H. 2003. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct. Funct. 28:105-112.
34. Gurujeyalakshmi, G., and Giri, S.N. 1995. Molecular mechanisms of antifibrotic effect of Interferon gamma in bleomycin-mouse model of lung fibrosis: down regulation of TGF-beta and procollagen I and III gene expression. Exp. Lung Res. 21:791-808.
35. Piguet, P.F., Vesin, C., Grau, G.E., and Thompson, R.C. 1993. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. Cytokine. 5:57-61.
36. Piguet, P.F., Vesin, C., and Thomas, F. 1995. Bombesin down modulates pulmonary fibrosis elicited in mice by bleomycin. Exp. Lung Res. 21:227-237.
37. Keane, M.P., et al. 1999. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J. Immunol. 163:5686-5692.
38. Keane, M.P., Belperio, J.A., Burdick, M.D., and Strieter, R.M. 2001. IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L92-L97.
39. Keane, M.P., et al. 1999. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162:5511-5518.
40. Clark J.G., Milberg, J.A., Steinberg, K.P., and Hudson, L.D. 1995. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann. Intern. Med. 122:17-23.
41. Martin, C., Papazian, L., Payan, M.J., Saux, P., and Gouin, F. 1995. Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients. Chest. 107:196-200.
42. Pugin, J., Verghese, G., Widmer, M.C., and Matthay, M.A. 1999. The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit. Care Med. 27:304-312.
43. Serini, G., and Gabbiani, G. 1999. Mechanisms of myofibroblast activity and phenotypic modulation. Exp. Cell Res. 250:273-283.
44. Zhang, K., Rekhter, M.D., Gordon, D., and Phan, S.H. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145:114-125.
45. Vicente-Manzanares, M., et al. 1999. Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis. J. Immunol. 163:4001-4012.
46. Sotsios, Y., Whittaker, G.C., Westwick, J., and Ward, S.G. 1999. The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes. J. Immunol. 163:5954-5963.
47. Suzuki, Y., Rahman, M., and Mitsuya, H. 2001. Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J. Immunol. 167:3064-3073.
48. Cardone, M.H., et al. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1318-1321.
49. Brunet, A., et al. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
50. Belperio, J.A, et al. 2002. Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 27:419-427.